-
STAT+: Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
24 Oct 2025 10:33 GMT
… cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is … will be made by Beximco Pharmaceuticals, a generic company based in …
-
The predictive validity crisis: Pharma’s productivity paradox – Part II
24 Oct 2025 10:35 GMT
… . Success stories from Vertex, Regeneron and AstraZeneca … about model requirements than pharmaceutical companies assume. In … Vertex’s example, may finally reverse the decades-long decline in pharmaceutical … the CEO of Etheros Pharmaceuticals Corp, which is …
-
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
24 Oct 2025 10:05 GMT
… -
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today … ALYFTREK and TRIKAFTA.
About Vertex
Vertex is a global biotechnology company … available.
(VRTX-GEN)
Contacts
Vertex Pharmaceuticals Incorporated
Investors:
InvestorInfo@vrtx. …
-
Sun Pharma Announces Allen as VP, Corporate Affairs for North America
23 Oct 2025 21:24 GMT
… 23, 2025
Princeton-based Sun Pharmaceutical Industries Limited announced the appointment … policy initiatives. Jeremy joins Sun Pharma from Spark Therapeutics, where he … held government affairs roles at Vertex Pharmaceuticals and Johnson & Johnson. Allen …
-
Vertex announces Registration of ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class CFTR Modulator for the Treatment of Cystic Fibrosis
21 Oct 2025 05:45 GMT
Vertex Pharmaceuticals today announced that Medsafe has … Dr. Kasia Siwek, Medical Director, Vertex Pharmaceuticals Australia and New Zealand.
The …
-
Chronic Obstructive Pulmonary Disease Drugs Market to Reach USD 30.13 Billion by 2032
24 Oct 2025 06:48 GMT
…
Abbott Laboratories (United States)
Vertex Pharmaceuticals (United States)
Europe
GlaxoSmithKline … (Finland)
Asia Pacific
Sun Pharmaceutical Industries Ltd. (India)
… Zydus Cadila (India)
Takeda Pharmaceutical Company Limited (Japan)
South …
-
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
23 Oct 2025 15:42 GMT
… for cystic fibrosis, such as Vertex Pharmaceuticals’ Trikafta and the recently approved …
-
Sanofi drug acquired in buyout succeeds in rare disease trial
22 Oct 2025 18:33 GMT
French pharmaceutical company Sanofi said Wednesday an … interference, among other approaches. And Vertex Pharmaceuticals has suffered multiple setbacks in …
-
Complement 3 Glomerulopathy Market Poised for Phenomenal Expansion at a CAGR of 37.2% During the Forecast Period (2025–2034) Owing to the Launch of Promising Therapies Targeting C3, C5, MASP-3, and RNAi | DelveInsight
22 Oct 2025 17:00 GMT
… -La Roche, Ionis Pharmaceuticals, AstraZeneca (Alexion Pharmaceuticals), Vertex Pharmaceuticals, Otsuka Pharmaceutical, Biogen, Arrowhead Pharmaceuticals, NovelMed, Q32 …
-
Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight
21 Oct 2025 22:44 GMT
… ., Pulmotect, Inc., Tetherex Pharmaceutical, CSL Behring, AstraZeneca, Novartis, Genentech, Vertex Pharmaceuticals, EmeraMed, Afimmune, Mereo BioPharma, Synairgen, Adamis Pharmaceuticals, Quercegen Pharmaceuticals LLC, Regend Therapeutics …
About
© 1995-2025